Shareholders' equity · 2011–2025
Akebia Therapeutics shareholders' equity
$32.6M+$81.8M · FY2025
Akebia Therapeutics (AKBA) reported $32.6M in shareholders' equity for fiscal 2025, +$81.8M from the year before.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $32.6M | +$81.8M | Open → |
| FY20242024-12-31 | −$49.2M | −$18.6M | Open → |
| FY20232023-12-31 | −$30.6M | −$35.8M | Open → |
| FY20222022-12-31 | $5.2M | −92.9% | Open → |
| FY20212021-12-31 | $74.0M | −69.7% | Open → |
| FY20202020-12-31 | $244M | −37.8% | Open → |
| FY20192019-12-31 | $393M | −38.2% | Open → |
| FY20182018-12-31 | $636M | +418.8% | Open → |
| FY20172017-12-31 | $123M | +79.9% | Open → |
| FY20162016-12-31 | $68.1M | −48.0% | Open → |
| FY20152015-12-31 | $131M | +25.9% | Open → |
| FY20142014-12-31 | $104M | +$231M | Open → |
| FY20132013-12-31 | −$127M | −$67.5M | Open → |
| FY20122012-12-31 | −$59.6M | −$11.4M | Open → |
| FY20112011-12-31 | −$48.2M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Akebia Therapeutics shareholders' equity |url=https://companiesranked.com/en/company/akebia-therapeutics/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Akebia Therapeutics shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/akebia-therapeutics/shareholders-equityBibTeX
@misc{companiesranked-en-company-akebia-therapeutics-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Akebia Therapeutics shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/akebia-therapeutics/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001517022-26-000051 · August 5, 2026
{{cite web |title=Akebia Therapeutics shareholders' equity — 10-Q (0001517022-26-000051) |url=https://www.sec.gov/Archives/edgar/data/1517022/000151702226000051/akba-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.